click below
click below
Normal Size Small Size show me how
ch. 21-24
P.cology 3--Exam 1
| Question | Answer |
|---|---|
| AMPA | IONOTROPIC Glutamate Receptor perm to Na+=EPSP |
| Kinate | IONOTROPIC Glutamate Receptor perm to Na+ = EPSP |
| NMDA | INOTROPIC Glutamate Receptor perm to Na+ & Ca++ = EPSP voltage & ligand gated |
| NMDA MOA | Glutamate binds both AMPA & NMDA (blocked by MG++) at same time. Binding allows Na+ to come in via AMPA causing depolarization which removes NMDAs Mg++ block, allowing Ca++ to enter. More Ca++ increases # of AMPA Rs causing NMDA to respond faster |
| NMDA receptors are important in... | long term potentiation/ Learning & Memory |
| GABAa | INOTROPIC controls Cl- channels=IPSP where alcohol, barbiturates, & BZDs bind |
| GABAb | METABOTROPIC control K+ channels= IPSP also found presynaptically--cause hyperpolarization in axon terminus |
| GABAc | controls Cl- channels prominent in retina |
| glycine | inhibitory NT controls Cl- channels=IPSP only in brainstem & spinal cord |
| nucleus/nuclei | collection of cell bodies in CNS |
| ganglion/ganglia | collection of cell bodies in PNS |
| Nicotinic Receptors | INOTROPIC--bind Ach influx of Na & efflux of K=EPSP (more Na out than K in) |
| Muscarinic Receptors | Metabotropic--bind ACh M1-M5 |
| M1 | decrease K conductance via IP3 & DAG= EPSP |
| M2 | increase K conductance via cAMP= IPSP |
| M1, M3, M4 | most abundant muscarinic Rs--found in brain |
| tyrosine hydroxylase | tyrosine--> Dopa rate limiting step |
| COMT | degrades catecholamines extracellularly but is membrane bound |
| MOA | degrades catecholamines inside cell |
| Dopamine Receptors | METABOTROPIC D1-D5 |
| D1 & D5 | increase cAMP via Gs = IPSP |
| D2, D3, D4 | decrease cAMP, increasing K+ conductance = IPSP |
| primary way dopamine is removed from synapse | taken back up via DAT---only 20% degraded by COMT |
| iocus coeruleus | major nucleus of NE pathway---produces NE |
| NE is removed from synapse by... | reuptake via NET, only 20% degraded by COMT |
| B1, B2, & A1 | depolarize neurons by blocking K+ conductance |
| A2 | hyperpolarizes neurons by increasing K+ conductance |
| What NE receptors are found presynaptically & limit NT release? | A2: feedback inhibition B2: feedback excitation |
| ______ is the only inotropic serotonin receptor | 5-HT3--Na (in)/ K(out) = EPSP |
| what 3 BZDs undergo only Phase 2 metabolism | lorazepam, oxazepam, temazepam |
| BZDs bind what receptor & cause _____ to happen | GABAa Rs--increase freq of Cl- channel opening & increase amplitude of IPSP |
| Barbiturates bind what receptor & cause ______ to happen? | GABAa Rs--increase duration of channel opening, increasing duration of IPSP |
| Barbiturates inhibit what other receptor? | AMPA--causes an overall inhibiting effect, b/c normally an EPSP |
| 3 new hypnotics | zolpidem, zalepion, eszopiclone |
| where do new hypnotics bind & what are they indicated for | bind GABAa isoforms w/ alpha1 subunits indicated for insomnia |
| Rameleton | melatonin receptor AGONIST @ MT1 & MT2 in suprachiasmic nucleus---extensive 1st pass metabolism |
| Buspirone | full/partial AGONIST @ 5-HT1 & D2 ANTAGONIST---only used as anxiolytic |
| Fluamzenil | BZD ANTAGONIST: #actions of BZDs, eszopiclone, zaleplon, zolpidem |
| Beta Carbolines | BZD INVERSE AGONISTS: bind BZD site & reduce freq of channel opening--actually cause anxiety & seizures |
| what receptor does alcohol bind & what does it make happen | binds GABAa receptors increasing duration of opening & increasing duration of IPSP |
| Naltrexone | Mu opioid receptor ANTAGONIST reduces short term cravings |
| Acamprosate | weak NMDA receptor ANTAGONIST & GABA activator--reduces short & long term relapse rates |
| Disulfram | inhibits aldehyde dehydrogenase--prevents acetaldehyde from being broken down into acetate |
| 1st gen anti-seizure drugs | phenobarbital, phenytoin, primidone, ethosuxemide, bzds, carbamazepine, valproate |
| 2nd gen anti-seizure drugs | gabapentin, lamotrigine, topiramate, oxcarbazepine, levatriacetam, zonisamide |
| act on voltage gated Na+ channels | phenytoin, carbmazepine, valproate, lamotrigine, topiramate, zonisamide |
| which gates cause refractory periods | inactivated Na+ channels |
| Phenytoin | elim is dose dependent (1st order)--also decreases synaptic release of glutamate & increases GABA release |
| Fosphenytoin | prodrug (Phenytoin), more soluble, less alkaline |
| Carbmazepine | half-life of 36h after single dose but drops to 8-12h in continuous therapy--monitor carefully |
| Carbamazepine black box warning | agranulocytosis, aplastic anemia, SJS, TENS |
| Valproate | prolongs Na channel inactivation, inhibits low threshold Ca currents, increases GABA levels |
| Valproate black box warning | hepatotoxicity (hyperammonemia), pancreatitis, teratogenicity--D |
| Lamotrigine black box warning | rashes & SJS |
| Topiramate AE | metabolic acidosis due to interactions w/ carbonic anhydrase |
| Zonisamide AE | cognitive impairment & schizophrenic syndrome |
| pregnancy cat. C | Lamotrigine, Topiramate, Zonisamide, Gabapentin, Tigabine, Levetriacetam |
| drugs that enhance GABA action | Diazepam/phenobarb, Valproate, Gabapentin, Tiagabine |
| diazepam & bzds | allosteric binders of GABAa--increase freq of opening & increase amplitude of IPSP |
| phenobarbital | increase duration of GABAa channel opening & increase duration of IPSP--also prolongs inactivation of Na channels & blocks Ca currents |
| Gabapentin | increase levels of GABA in brain by binding voltage gated Ca channels that decrease glutamate release |
| Tiagabine | inhibitor of GABA uptake by neurons and glial cells by inhibiting GAT-1 |
| drugs that inhibit low threshold Ca currents are useful for which seizures? | absence seizures |
| drugs that inhibit low threshold Ca currents | Ethosuxamide, Levetriacetam, Valproate, Phenobarbital |
| Ethosuxamide | reduces low threshold Ca currents in thalamic neurons to decrease cortical discharge |
| Levetriacetam | targets synaptic vesicle protein SV2A, blocks some Ca channels, blocks Beta Carbolines from binding GABAa but doesnt bind receptor itself |